The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent Manner
Open Access
- 1 November 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 283 (45), 30471-30481
- https://doi.org/10.1074/jbc.m802185200
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Agonist potency at P2X7 receptors is modulated by structurally diverse lipidsBritish Journal of Pharmacology, 2007
- The role of the purinergic P2X7 receptor in inflammationJournal of Inflammation, 2007
- Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptorThe EMBO Journal, 2006
- A role for P2X7 in microglial proliferationJournal of Neurochemistry, 2006
- LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2006
- Potentiation of Native and Recombinant P2X7-Mediated Calcium Signaling by Arachidonic Acid in Cultured Cortical Astrocytes and Human Embryonic Kidney 293 CellsMolecular Pharmacology, 2006
- Antimicrobial protein hCAP18/LL‐37 is highly expressed in breast cancer and is a putative growth factor for epithelial cellsInternational Journal of Cancer, 2005
- Hetero-assembly Between All-l- and All-d-Amino Acid Transmembrane Domains: Forces Involved and Implication for Inactivation of Membrane ProteinsJournal of Molecular Biology, 2004
- Antimicrobial peptides of multicellular organismsNature, 2002
- Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37Journal of Biological Chemistry, 1998